TECH - BIO-TECHNE Corp
57.85
0.860 1.487%
Share volume: 2,194,448
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$56.99
0.86
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 05-06-2024 | 01-07-2025 | 11-05-2024 | 02-06-2025 | 05-08-2025 | 08-22-2025 | 11-05-2025 | 02-04-2026 | |
| Assets | |||||||||
| Total Assets | 2.721 B | 2.704 B | 2.736 B | 2.670 B | 2.644 B | 2.558 B | 2.526 B | 2.523 B | |
| Current Assets | 610.650 M | 617.419 M | 648.567 M | 634.640 M | 627.240 M | 608.300 M | 609.507 M | 637.432 M | |
| Inventories | 179.496 M | 179.731 M | 185.041 M | 188.373 M | 191.083 M | 189.446 M | 203.188 M | 205.447 M | |
| Other Current Assets | 31.286 M | 33.658 M | 42.839 M | 49.731 M | 53.647 M | 37.460 M | 77.460 M | 74.492 M | |
| Short Term Investments | 5.397 M | 1.072 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 139.915 M | 151.791 M | 187.540 M | 177.549 M | 140.670 M | 162.186 M | 144.962 M | 172.879 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 243.728 M | 251.154 M | 253.939 M | 249.753 M | 251.977 M | 245.719 M | 240.334 M | 234.383 M | |
| Other Assets | 1.867 B | 1.835 B | 1.834 B | 1.786 B | 1.765 B | 1.704 B | 1.676 B | 1.651 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.721 B | 2.704 B | 2.736 B | 2.670 B | 2.644 B | 2.558 B | 2.526 B | 2.523 B | |
| Total liabilities | 706.795 M | 635.017 M | 597.367 M | 591.932 M | 626.234 M | 639.060 M | 560.334 M | 511.710 M | |
| Total current liabilities | 149.820 M | 159.379 M | 142.128 M | 161.256 M | 169.204 M | 175.849 M | 144.545 M | 140.426 M | |
| Accounts Payable | 28.895 M | 37.968 M | 31.559 M | 33.120 M | 31.644 M | 25.311 M | 30.157 M | 26.269 M | |
| Other liabilities | 104.309 M | 100.775 M | 105.222 M | 92.953 M | 95.106 M | 111.042 M | 104.516 M | 100.263 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 389.000 M | 319.000 M | 300.000 M | 300.000 M | 330.000 M | 346.000 M | 300.000 M | 260.000 M | |
| Other liabilities | 104.309 M | 100.775 M | 105.222 M | 92.953 M | 95.106 M | 111.042 M | 104.516 M | 100.263 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.014 B | 2.069 B | 2.139 B | 2.078 B | 2.018 B | 1.919 B | 1.966 B | 2.011 B | |
| Common stock | 791.994 M | 821.919 M | 857.562 M | 877.443 M | 903.692 M | 912.639 M | 947.675 M | 966.514 M | |
| Retained earnings | 1.298 B | 1.325 B | 1.341 B | 1.287 B | 1.196 B | 1.066 B | 1.083 B | 1.107 B |